Friday - January 30, 2026

Category Archives: Pharmaceuticals & Biotech

Triple Negative Breast Cancer Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ModernaTX, Inc., OncoTherapy Science, Phoenix Molecular

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Triple Negative Breast Cancer pipeline constitutes 165+ key companies continuously working towards developing 170+ Triple Negative Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Osteoarthritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Osteoarthritis pipeline constitutes 100+ key companies continuously working towards developing 110+ Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Focal Segmental Glomerulosclerosis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | B. Braun Melsungen, Beckman Coulter (Danaher), Baxter

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Focal Segmental Glomerulosclerosis pipeline constitutes 15+ key companies continuously working towards developing 18+ Focal Segmental Glomerulosclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

ANX-007 A Comprehensive Forecast on the Accelerating Market Growth for Dry age-related macular degeneration by 2034

A leading healthcare research firm releases an in-depth ANX-007 market report, covering sales forecast, market size analysis, and insights through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on … Continue reading →

Aviceda Therapeutics “AVD-104” Market size expansion of Several Folds by 2034

DelveInsight unveils an in-depth report on AVD-104 by Aviceda Therapeutics, featuring market landscape insights and sales forecasts through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on AVD-104 (Aviceda … Continue reading →

IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight

DelveInsight’s “IgG4-Related Disease Market Insights, Epidemiology, and Market Forecast- 2034” report delivers an in-depth understanding of the IgG4-Related Disease, historical and forecasted epidemiology and the IgG4-Related Disease market trends in the United States, EU4 (Germany, France, Italy, and Spain) and … Continue reading →

Spinal Cord Injury Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America

Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast – 2034 The Key Spinal Cord Injury Companies in the market include – Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America, among others. The Spinal Cord Injury market is expected … Continue reading →